This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Henry Schein Elects Dr. E. Dianne Rekow To Board Of Directors

MELVILLE, N.Y., June 3, 2014 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today the election of Professor E. Dianne Rekow, D.D.S., Ph.D., to the Company's Board of Directors.  Dr. Rekow, Dean of King's College London Dental Institute and Professor of Orthodontics, brings to the Henry Schein Board extensive experience in innovative dental products, practices, and education, as well as keen insights into global trends influencing the evolution of the dental profession.

Dr. E. Dianne Rekow elected to Henry Schein, Inc. Board of Directors

"In a global dental environment that is quickly evolving through the power of digital technology, we are very pleased to welcome Dr. Rekow to the Henry Schein Board of Directors," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Dr. Rekow is a recognized pioneer in the field of digital dentistry, an expert in the development and performance of dental materials and products, and a global thought leader in dental education.  We look forward to benefitting from her unique perspective and strategic insights, as Henry Schein continues to focus on providing digital dental solutions to our customers around the world."

Dr. Rekow has a long and distinguished career in dentistry, including a decade as a Professor of Orthodontics at New York University, as well as senior roles at multiple dental and scientific associations.  An internationally recognized authority on the performance of new materials and products for use in aesthetic and restorative dentistry, Dr. Rekow has been a leader in research on the use of bio-engineered tissue to facilitate bone replacement in individuals who have been disfigured by disease or developmental defects as well as research in elucidating damage initiation and propagation in brittle materials. Dr. Rekow also holds a number of patents in the dental field and is the author of, or contributor to, more than one hundred publications.

"It is a pleasure to join the Board of a company that is committed to technology leadership in all facets of its business," said Dr. Rekow.  "Not only has Henry Schein been a pioneer in meeting the needs of its dental, animal health and medical customers for decades, but through its continual reinvention of the organization, Henry Schein has also helped recreate and advance the markets that it serves.  I look forward to being part of such a future-focused company and to helping Henry Schein sustain the admirable leadership role it has forged."     

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,954.66 -115.74 -0.64%
S&P 500 2,096.31 -18.18 -0.86%
NASDAQ 4,949.8510 -67.0780 -1.34%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs